"10.1371_journal.pone.0097864","plos one","2014-05-27T00:00:00Z","Mikko T Nieminen; Lily Novak-Frazer; Vilma Rautemaa; Ranjith Rajendran; Timo Sorsa; Gordon Ramage; Paul Bowyer; Riina Rautemaa","Research Unit on Acetaldehyde and Cancer, University of Helsinki, Helsinki, Finland; Department of Periodontology, Institute of Dentistry, University of Helsinki, Helsinki, Finland; Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Helsinki, Finland; Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital Finland, Helsinki, Finland; The University of Manchester, Institute of Inflammation and Repair, Manchester Academic Health Science Centre, University Hospital of South Manchester, Wythenshawe Hospital, Manchester, United Kingdom; Infection and Immunity Research Group, Glasgow Dental School and Hospital, School of Medicine, College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom","Conceived and designed the experiments: MN LNF GR PB R. Rautemaa. Performed the experiments: MN LNF VR R. Rajendran. Analyzed the data: MN LNF VR GR PB R. Rautemaa. Contributed reagents/materials/analysis tools: TS GR PB R. Rautemaa. Wrote the paper: MN LNF R. Rajendran TS GR PB R. Rautemaa.","I have read the journal's policy and have the following conflicts: TS is one of the inventors of European Patent Office patent EP0871438B1: “Use of alpha-hydroxy acids in the manufacture of a medicament for the treatment of inflammation”. The patent is owned by Extracta Oy Ltd., Helsinki, Finland. TS has not received any royalties regarding this patent. GR has acted as a consultant and a speaker for Gilead Sciences, Astellas, Merck Sharp & Dohme, GlaxoSmithKline, BluTest Laboratories and Fulhold Ltd. This does not alter our adherence to all the PLOS One policies on sharing data and materials.","2014","05","Mikko T Nieminen","MTN",8,TRUE,5,4,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
